Cabelando, Agape .

HRN: 26-09-21  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/29/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/29/2024
11/05/2024
IV
400mg
IV
R/O Appendicitis
Waiting Final Action 
10/30/2024
CEFUROXIME 750MG (VIAL)
10/27/2024
11/03/2024
IV
750mg
Q8
Acute Gastritis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: